ERBB2 and breast carcinoma: Furthermore, mouse models of ErbB2-induced breast cancer and Ras-induced lung or pancreatic cancer demonstrate that expression of these oncogenes in epithelial cells while inducing in situ carcinoma they rarely induce metastases, suggesting that additional events are likely to be required for metastatic progression [13], [14].